These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17406654)

  • 1. Evaluation of reference regions for (R)-[(11)C]PK11195 studies in Alzheimer's disease and mild cognitive impairment.
    Kropholler MA; Boellaard R; van Berckel BN; Schuitemaker A; Kloet RW; Lubberink MJ; Jonker C; Scheltens P; Lammertsma AA
    J Cereb Blood Flow Metab; 2007 Dec; 27(12):1965-74. PubMed ID: 17406654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
    J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography study.
    Schuitemaker A; Kropholler MA; Boellaard R; van der Flier WM; Kloet RW; van der Doef TF; Knol DL; Windhorst AD; Luurtsema G; Barkhof F; Jonker C; Lammertsma AA; Scheltens P; van Berckel BN
    Neurobiol Aging; 2013 Jan; 34(1):128-36. PubMed ID: 22840559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies.
    Yaqub M; van Berckel BN; Schuitemaker A; Hinz R; Turkheimer FE; Tomasi G; Lammertsma AA; Boellaard R
    J Cereb Blood Flow Metab; 2012 Aug; 32(8):1600-8. PubMed ID: 22588187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of reference tissue models for the analysis of [11C](R)-PK11195 studies.
    Kropholler MA; Boellaard R; Schuitemaker A; Folkersma H; van Berckel BN; Lammertsma AA
    J Cereb Blood Flow Metab; 2006 Nov; 26(11):1431-41. PubMed ID: 16511500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of methods for generating parametric (R-[11C]PK11195 binding images.
    Schuitemaker A; van Berckel BN; Kropholler MA; Kloet RW; Jonker C; Scheltens P; Lammertsma AA; Boellaard R
    J Cereb Blood Flow Metab; 2007 Sep; 27(9):1603-15. PubMed ID: 17311080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease.
    Tomasi G; Edison P; Bertoldo A; Roncaroli F; Singh P; Gerhard A; Cobelli C; Brooks DJ; Turkheimer FE
    J Nucl Med; 2008 Aug; 49(8):1249-56. PubMed ID: 18632810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference and target region modeling of [11C]-(R)-PK11195 brain studies.
    Turkheimer FE; Edison P; Pavese N; Roncaroli F; Anderson AN; Hammers A; Gerhard A; Hinz R; Tai YF; Brooks DJ
    J Nucl Med; 2007 Jan; 48(1):158-67. PubMed ID: 17204713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPM analysis of parametric (R)-[11C]PK11195 binding images: plasma input versus reference tissue parametric methods.
    Schuitemaker A; van Berckel BN; Kropholler MA; Veltman DJ; Scheltens P; Jonker C; Lammertsma AA; Boellaard R
    Neuroimage; 2007 May; 35(4):1473-9. PubMed ID: 17363280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?
    Bartels AL; Willemsen AT; Doorduin J; de Vries EF; Dierckx RA; Leenders KL
    Parkinsonism Relat Disord; 2010 Jan; 16(1):57-9. PubMed ID: 19487152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies.
    Klumpers UM; Veltman DJ; Boellaard R; Comans EF; Zuketto C; Yaqub M; Mourik JE; Lubberink M; Hoogendijk WJ; Lammertsma AA
    J Cereb Blood Flow Metab; 2008 Mar; 28(3):579-87. PubMed ID: 17928801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.
    Lopresti BJ; Klunk WE; Mathis CA; Hoge JA; Ziolko SK; Lu X; Meltzer CC; Schimmel K; Tsopelas ND; DeKosky ST; Price JC
    J Nucl Med; 2005 Dec; 46(12):1959-72. PubMed ID: 16330558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference tissue models and blood-brain barrier disruption: lessons from (R)-[11C]PK11195 in traumatic brain injury.
    Folkersma H; Boellaard R; Vandertop WP; Kloet RW; Lubberink M; Lammertsma AA; van Berckel BN
    J Nucl Med; 2009 Dec; 50(12):1975-9. PubMed ID: 19910429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195.
    Anderson AN; Pavese N; Edison P; Tai YF; Hammers A; Gerhard A; Brooks DJ; Turkheimer FE
    Neuroimage; 2007 May; 36(1):28-37. PubMed ID: 17398120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.
    Catafau AM; Danus M; Bullich S; Llop J; Perich J; Cunningham VJ; Plaza P; Penengo MM; Eersels JL; Squassante L; Ros D; Barbanoj M
    J Nucl Med; 2006 Jun; 47(6):919-28. PubMed ID: 16741300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.
    Price JC; Klunk WE; Lopresti BJ; Lu X; Hoge JA; Ziolko SK; Holt DP; Meltzer CC; DeKosky ST; Mathis CA
    J Cereb Blood Flow Metab; 2005 Nov; 25(11):1528-47. PubMed ID: 15944649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cluster analysis in kinetic modelling of the brain: a noninvasive alternative to arterial sampling.
    Liptrot M; Adams KH; Martiny L; Pinborg LH; Lonsdale MN; Olsen NV; Holm S; Svarer C; Knudsen GM
    Neuroimage; 2004 Feb; 21(2):483-93. PubMed ID: 14980551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.
    Mosconi L; Tsui WH; De Santi S; Li J; Rusinek H; Convit A; Li Y; Boppana M; de Leon MJ
    Neurology; 2005 Jun; 64(11):1860-7. PubMed ID: 15955934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.